Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development ... (Regulatory Affairs at Reata Pharmaceutic...)

Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities

Date:7/28/2008

Regulatory Affairs at Reata Pharmaceuticals. He has held leadership clinical development and medical affairs positions at IDEC Pharmaceuticals Corporation, Biogen Idec and Alpha Therapeutic and also has experience in the medical device arena, previously holding director positions at Abbot Laboratories and Dade Behring. He is Board Certified in Internal Medicine and Hematology. He received his B.S. degree in Chemistry from the University of Michigan, and his M.D. degree and medical training at Duke University.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications. Cardium's lead product candidate, Generx(TM) (alferminogene tadenovec, Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more information about Cardium and its businesses, products and therapeutic candidates, please visit http://www.cardiumthx.com or view its 2007 Annual Report at http://www.cardiumthx.com/flash/pdf/CardiumAR07_Book_FINAL.pdf.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of patient temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results

Post Your Comments:

(Date:5/23/2013)... May 23, 2013 More than half of ... benefit from chemotherapy and still have excellent outcomes. To ... one of the largest sources of online consumer information ... interactive Facebook page provide recently diagnosed women with information ... avoid chemotherapy. "We anticipate these innovative social ...

(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...

(Date:5/23/2013)... -- Ameritox, the nation,s leader in pain medication monitoring, ... become part of its Urine Drug Monitoring (UDM) ... improve the clinical outcomes for injured workers. ... in the workers, compensation industry, has used UDM ... strategy for several years. By establishing a comprehensive ...

Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2 Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3 TMA Launches Physician Services Organization for Patient Care 2 TMA Launches Physician Services Organization for Patient Care 3 TMA Launches Physician Services Organization for Patient Care 4 Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2 Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3

[0] Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions [0] TMA Launches Physician Services Organization for Patient Care [0] Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers

... NeutronicEar, the leader in Personal Sound Amplification ... pricing on their newly re-designed website www.neutronicear.com ... products as well as discounted pricing on consumable ... The NeutronicEar PASP was designed as an ...

... 2012 Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... increased from $6.50 to $7.50 per share in cash ... acquire ISTA Pharmaceuticals Inc. (Nasdaq: ISTA). Valeant also communicated ... a price of up to $8.50 per share, assuming ...

NeutronicEar Launches Direct-To-Consumer Website Valeant Pharmaceuticals Increases Proposed Price for Acquisition of ISTA Pharmaceuticals Inc. to $7.50 Per Share in Cash

(Date:5/24/2013)... HealthDay Reporter , , FRIDAY, May 24 (HealthDay ... are remarkable. But it was a physical challenge in ... of her sport. "I was an 11-year-old girl ... scoliosis was diagnosed by my orthopedic surgeon," said Lewis, ... Research Society and the American Academy of Orthopaedic Surgeons ...

(Date:5/24/2013)... 24, 2013 ResortQuest Real Estate® is ... Dayna Feher team at the firm’s Bethany Beach location. ... resorts her home in 1975. Her real estate career ... all aspects of the real estate business - receptionist, ... 12 years, a licensed sales associate. , “I ...

(Date:5/24/2013)... 24, 2013 The Mirena IUD lawyers ... news that the FDA has received more than 59,229 complaints ... from the intrauterine birth control device known as the Mirena ... issues reported by the women “included ‘expulsion,’ where the IUD ... that occurring,” according to an ABC News article. “Abdominal pain ...

(Date:5/24/2013)... CHI-California Healthcare Institute today submitted ... congressional delegation, joined by over 40 biomedical companies, ... paid to the U.S. Food and Drug Administration ... cuts will not include user fees paid to ... Development and FDA Appropriations Bill. CHI is a ...

(Date:5/24/2013)... Started in 1982, AMTC’s SHINE event is ... marks AMTC’s 31st anniversary. SHINE is a ministry run by ... Lewis and her daughter, Carey Lewis Arban. , This summer’s ... and music professionals including the New York Film Academy, The ... are kings of Hollywood and Christian casting directors. They seek ...

Breaking Medicine News(10 mins):Health News:Top-Ranked Golfer Beats Scoliosis 2 Health News:Top-Ranked Golfer Beats Scoliosis 3 Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2 Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3 Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2

[0] Top-Ranked Golfer Beats Scoliosis [0] Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team [0] Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes [0] California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 [0] AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013

... some states have cut breast cancer screening programs , TUESDAY, ... mammograms for women ages 40 to 49 has decreased since ... the U.S. Preventive Services Task Force, according to a new ... risk for breast cancer should start having mammograms every two ...

... at the Mayo Clinic campus in Florida have found ... lung cancers, is over-produced in pancreatic cancer and is ... genetically inhibiting PKC in laboratory animals led to a ... The discovery, reported in the March 1 issue of ...

... ... ... ... ...

... often think about hot flashes, hormone shifts and mood swings. ... of heart disease intensifies drastically around the time of natural menopause, ... This news may come as a surprise, but experts explain that ... that there are ways to lower your risk. ...

... ... at the Parallels Summit 2010 , ... Miami, FL (PRWEB) February 23, 2010 -- Worldwide cloud enablement leader, ... Parallels Summit 2010., , ,Highlighting excellence in the industry, the awards recognize the outstanding ...

... ... ... ... ...

Access to Mammograms Drops After Guidelines Change Mayo Clinic researchers find oncogene is important in pancreatic cancer growth and spread Monique da Silva Joins Ogilvy Public Relations Worldwide to Lead North America Healthcare Practice Changes during menopause increases risk of heart disease and stroke Winners are Grinners at the Inaugural Parallels Partner Awards Jiffy Lube(R) Well On Its Way to Raising Another $1 Million to Fight Heart Disease

Rhoton Curettes, titanium, length 191 mm, straight....

Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....

Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....

Medicine Products:

Rhoton Curettes Micro Needle Holder Vascular Clamps ABB-11 Vascular Clamps B-1